Ever since the founding in 1985 of TAP Pharmaceutical Products Inc., the 50/50 joint venture with Abbott Laboratories Inc., Takeda Pharmaceutical Co. Ltd. had been viewed as a bi-modal company focusing on its domestic Japanese market and on the US.
TAP can be viewed as Takeda’s first significant global expansion. It was through TAP that Takeda eventually cut its teeth...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?